Would An NIH Grant Lottery Aide Funding Efforts?
Executive Summary
Because it is now increasingly difficult to obtain an NIH grant, two scientists argue in a Wall Street Journal opinion article that the agency should determine grantees randomly instead.
You may also be interested in...
Sequestration Day: FDA Will Manage For Now, But Could Suffer Later If Hiring Deferred
As the across-the-board cuts go into effect, not allowing FDA to add the hundreds of new employees that will be needed to meet the goals of user fee and other programs could damage the agency for years to come; NIH and CMS also will see significant effects.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.
Gene Therapy: Pediatric Development Could Start Sooner Than Sponsors Think – FDA OTP Director
Nicole Verdun said children could participate in gene therapy clinical trials earlier if the necessary controls are in place.